David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MXIM
2901
CALL
DELISTED
Maxim Integrated Products
MXIM
| $477K | ﹤0.01% |
10,000
| – | – |
|
|
AAIC
2902
DELISTED
Arlington Asset Investment Corp.
AAIC
| $474K | ﹤0.01% |
+37,264
| New | +$492K |
|
2903
CALL
Dine Brands
DIN
$457M
| $473K | ﹤0.01% |
11,000
-70,300
| -86% | -$2.87M |
|
2904
The Ensign Group
ENSG
$10.5B
| $473K | ﹤0.01% |
22,404
-49,305
| -69% | -$969K |
|
|
VBTX
2905
DELISTED
Veritex Holdings
VBTX
| $473K | ﹤0.01% |
+17,527
| New | +$461K |
|
|
JWN
2906
CALL
DELISTED
Nordstrom
JWN
| $472K | ﹤0.01% |
10,000
+1,000
| +11% | +$46.4K |
|
|
TTM
2907
PUT
DELISTED
Tata Motors Limited
TTM
| $472K | ﹤0.01% |
+15,100
| New | +$486K |
|
|
BEAT
2908
DELISTED
BioTelemetry, Inc.
BEAT
| $471K | ﹤0.01% |
14,265
-77,644
| -84% | -$2.69M |
|
2909
PUT
Freshpet
FRPT
$3.68B
| $470K | ﹤0.01% |
+30,000
| New | +$483K |
|
2910
Equity Bancshares
EQBK
$1.03B
| $469K | ﹤0.01% |
+13,176
| New | +$447K |
|
2911
Newell Brands
NWL
$2.59B
| $469K | ﹤0.01% |
+10,993
| New | +$538K |
|
2912
CALL
Shake Shack
SHAK
$3.05B
| $469K | ﹤0.01% |
+14,100
| New | +$461K |
|
2913
Axogen
AXGN
$2.65B
| $468K | ﹤0.01% |
+24,207
| New | +$407K |
|
|
HF
2914
DELISTED
HFF Inc.
HF
| $468K | ﹤0.01% |
11,819
-6,411
| -35% | -$236K |
|
2915
CALL
IMAX
IMAX
$3B
| $467K | ﹤0.01% |
+20,600
| New | +$425K |
|
|
GEN
2916
DELISTED
Genesis Healthcare, Inc.
GEN
| $466K | ﹤0.01% |
402,003
+40,641
| +11% | +$51.2K |
|
2917
PUT
Mattel
MAT
$4.23B
| $464K | ﹤0.01% |
+30,000
| New | +$536K |
|
2918
Movado Group
MOV
$772M
| $464K | ﹤0.01% |
+16,572
| New | +$421K |
|
|
VRE
2919
DELISTED
Veris Residential
VRE
| $464K | ﹤0.01% |
+19,563
| New | +$482K |
|
|
2920
PUT
Newell Brands
NWL
$2.59B
| $461K | ﹤0.01% |
+10,800
| New | +$528K |
|
2921
Oxford Square Capital
OXSQ
$150M
| $461K | ﹤0.01% |
67,314
-60,049
| -47% | -$403K |
|
|
FINL
2922
PUT
DELISTED
Finish Line
FINL
| $460K | ﹤0.01% |
38,200
+22,400
| +142% | +$268K |
|
2923
New Oriental
EDU
$8.97B
| $459K | ﹤0.01% |
5,204
-10,493
| -67% | -$855K |
|
|
GBL
2924
DELISTED
GAMCO Investors, Inc.
GBL
| $458K | ﹤0.01% |
15,390
-1,643
| -10% | -$48.8K |
|
2925
CALL
Kohl's
KSS
$2.08B
| $457K | ﹤0.01% |
10,000
| – | – |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.